Large gap with delayed quotes
|
Last quote
02/02/2026
-
22:15:00
|
Bid
02/02/2026 -
22:00:00
|
Bid Volume |
Ask
02/02/2026 -
22:00:00
|
Ask Volume |
|---|---|---|---|---|
|
21.44
+0.06
(
+0.28% )
|
21.44
|
6,100 |
21.45
|
2,900 |
Analysis date: 30.01.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 25.11.2025.
Interest
None
None
No stars since 27.01.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 06.01.2026 at a price of 22.29.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 27.01.2026.
4wk Rel Perf
-1.41%
-1.41%
The four-week dividend-adjusted underperformance versus SP500 is 1.41%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 25.11.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.01%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.66%.
Mkt Cap in $bn
1.84
1.84
With a market capitalization <$2bn, PEDIATRIX MEDICAL GROUP is considered a small-cap stock.
G/PE Ratio
0.79
0.79
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
9.30
9.30
The estimated PE is for the year 2027.
LT Growth
7.38%
7.38%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
6
6
Over the last seven weeks, an average of 6 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
60
60
For 1% of index variation, the stock varies on average by 0.60%.
Correlation
0.23
0.23
Stock movements are strongly independent of index variations.
Value at Risk
7.31
7.31
The value at risk is estimated at USD 7.31. The risk is therefore 34.18%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002